| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.2M | -29.8% |
| Cost of Revenue | $1.3M | -9.9% |
| Gross Profit | $1.9M | -39.2% |
| R&D Expense | $4.0M | -8.2% |
| SG&A Expense | $22.0M | +47.1% |
| Operating Income | -$37.0M | -37.3% |
| Interest Expense | $300K | -50.0% |
| Pre-tax Income | -$35.6M | -3.7% |
| Income Tax | $16K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -34.4% |
| Accounts Receivable | $706K | +24.3% |
| Inventory | $2.2M | -8.3% |
| Current Assets | $8.6M | -58.1% |
| Total Assets | $24.3M | +2.2% |
| Current Liabilities | $17.4M | +3.1% |
| Long-term Debt | $65K | -99.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.3M | +23.6% |
| Capital Expenditures | $68K | -60.5% |
| Investing Cash Flow | $2.9M | +148.5% |
| Financing Cash Flow | $23.6M | +6.1% |
| Free Cash Flow | -$22.4M | +23.9% |
| -33.3% |
| Net Income | -$35.6M | +22.5% |
| EPS (Basic) | -$162.78 | -113.0% |
| EPS (Diluted) | -$162.78 | -113.0% |
| Total Liabilities |
| $17.7M |
| +4.0% |
| Stockholders' Equity | $6.6M | +3.7% |